Biomarker-guided therapy for colorectal cancer: strength in complexity

A Sveen, S Kopetz, RA Lothe - Nature Reviews Clinical Oncology, 2020 - nature.com
The number of molecularly stratified treatment options available to patients with colorectal
cancer (CRC) is increasing, with a parallel rise in the use of biomarkers to guide …
被引用次数：267 相关文章

[引用][C] Biomarker-guided therapy for colorectal cancer: strength in complexity

A Sveen, S Kopetz, RA Lothe - Nature Reviews Clinical Oncology, 2019 - cir.nii.ac.jp
Biomarker-guided therapy for colorectal cancer: strength in complexity | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

Biomarker-guided therapy for colorectal cancer: strength in complexity.

A Sveen, S Kopetz, RA Lothe - Nature reviews. Clinical Oncology, 2019 - europepmc.org
The number of molecularly stratified treatment options available to patients with colorectal
cancer (CRC) is increasing, with a parallel increase in the use of biomarkers to guide …

Biomarker-guided therapy for colorectal cancer: strength in complexity

A Sveen, S Kopetz, RA Lothe - Nature reviews. Clinical …, 2020 - pubmed.ncbi.nlm.nih.gov
The number of molecularly stratified treatment options available to patients with colorectal
cancer (CRC) is increasing, with a parallel rise in the use of biomarkers to guide …
[HTML] nih.gov

[HTML][HTML] Biomarker-guided therapy for colorectal cancer: strength in complexity

A Sveen, S Kopetz, RA Lothe - Nature reviews. Clinical oncology, 2020 - ncbi.nlm.nih.gov
The number of molecularly stratified treatment options available to patients with colorectal
cancer (CRC) is increasing, with a parallel increase in the use of biomarkers to guide …

Biomarker-guided therapy for colorectal cancer: strength in complexity

A Sveen, S Kopetz, RA Lothe - Nature Reviews …, 2020 - mdanderson.elsevierpure.com
The number of molecularly stratified treatment options available to patients with colorectal
cancer (CRC) is increasing, with a parallel rise in the use of biomarkers to guide …